ACE2: from vasopeptidase to SARS virus receptor

The zinc metallopeptidase angiotensin-converting enzyme 2 (ACE2) is the only known human homologue of the key regulator of blood pressure angiotensin-converting enzyme (ACE). Since its discovery in 2000, ACE2 has been implicated in heart function, hypertension and diabetes, with its effects being me...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Trends in pharmacological sciences (Regular ed.) 2004-06, Vol.25 (6), p.291-294
Hauptverfasser: Turner, Anthony J, Hiscox, Julian A, Hooper, Nigel M
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 294
container_issue 6
container_start_page 291
container_title Trends in pharmacological sciences (Regular ed.)
container_volume 25
creator Turner, Anthony J
Hiscox, Julian A
Hooper, Nigel M
description The zinc metallopeptidase angiotensin-converting enzyme 2 (ACE2) is the only known human homologue of the key regulator of blood pressure angiotensin-converting enzyme (ACE). Since its discovery in 2000, ACE2 has been implicated in heart function, hypertension and diabetes, with its effects being mediated, in part, through its ability to convert angiotensin II to angiotensin-(1–7). Unexpectedly, ACE2 also serves as the cellular entry point for the severe acute respiratory syndrome (SARS) virus and the enzyme is therefore a prime target for pharmacological intervention on several disease fronts.
doi_str_mv 10.1016/j.tips.2004.04.001
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7119032</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0165614704000975</els_id><sourcerecordid>71966617</sourcerecordid><originalsourceid>FETCH-LOGICAL-c545t-d977b3ed0d5262376743a7f294bfa6dcd93e1ce5cbc3f8133d85b447b179c28a3</originalsourceid><addsrcrecordid>eNp9kMtKAzEUhoMotl5ewIXMyt20OcnMpCMilFIvUBCsrkMmOaMpbTMm04Jvb4YWLxvhQBb_d_4cPkIugA6AQjFcDFrbhAGjNBt0Q-GA9GEkeMoFzw9JP0J5WkAmeuQkhAWllHMGx6QHeUxEBn0yHE-m7DqpvVslWxVcg01rjQqYtC6Zj5_nydb6TUg86pg4f0aOarUMeL5_T8nr3fRl8pDOnu4fJ-NZqvMsb1NTClFxNNTkrGBcFCLjStSszKpaFUabkiNozHWleT0Czs0or7JMVCBKzUaKn5LbXW-zqVZoNK5br5ay8Xal_Kd0ysq_ydq-yze3lQKgpJzFgqt9gXcfGwytXNmgcblUa3SbELmyKAoQEWQ7UHsXgsf6-xOgsvMsF7LzLDvPshsKceny93k_K3uxEbjZARglbS16GbTFtUZjo8pWGmf_6_8C4qCOrg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71966617</pqid></control><display><type>article</type><title>ACE2: from vasopeptidase to SARS virus receptor</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Turner, Anthony J ; Hiscox, Julian A ; Hooper, Nigel M</creator><creatorcontrib>Turner, Anthony J ; Hiscox, Julian A ; Hooper, Nigel M</creatorcontrib><description>The zinc metallopeptidase angiotensin-converting enzyme 2 (ACE2) is the only known human homologue of the key regulator of blood pressure angiotensin-converting enzyme (ACE). Since its discovery in 2000, ACE2 has been implicated in heart function, hypertension and diabetes, with its effects being mediated, in part, through its ability to convert angiotensin II to angiotensin-(1–7). Unexpectedly, ACE2 also serves as the cellular entry point for the severe acute respiratory syndrome (SARS) virus and the enzyme is therefore a prime target for pharmacological intervention on several disease fronts.</description><identifier>ISSN: 0165-6147</identifier><identifier>EISSN: 1873-3735</identifier><identifier>DOI: 10.1016/j.tips.2004.04.001</identifier><identifier>PMID: 15165741</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Animals ; Blood Vessels - metabolism ; Blood Vessels - physiology ; Humans ; Isoenzymes - genetics ; Isoenzymes - physiology ; Peptide Hormones - metabolism ; Peptide Hormones - physiology ; Peptide Hydrolases - physiology ; Peptidyl-Dipeptidase A - genetics ; Peptidyl-Dipeptidase A - physiology ; Receptors, Virus - genetics ; SARS Virus - genetics</subject><ispartof>Trends in pharmacological sciences (Regular ed.), 2004-06, Vol.25 (6), p.291-294</ispartof><rights>2004 Elsevier Ltd</rights><rights>Copyright © 2004 Elsevier Ltd. All rights reserved. 2004 Elsevier Ltd</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c545t-d977b3ed0d5262376743a7f294bfa6dcd93e1ce5cbc3f8133d85b447b179c28a3</citedby><cites>FETCH-LOGICAL-c545t-d977b3ed0d5262376743a7f294bfa6dcd93e1ce5cbc3f8133d85b447b179c28a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.tips.2004.04.001$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,776,780,881,3536,27903,27904,45974</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15165741$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Turner, Anthony J</creatorcontrib><creatorcontrib>Hiscox, Julian A</creatorcontrib><creatorcontrib>Hooper, Nigel M</creatorcontrib><title>ACE2: from vasopeptidase to SARS virus receptor</title><title>Trends in pharmacological sciences (Regular ed.)</title><addtitle>Trends Pharmacol Sci</addtitle><description>The zinc metallopeptidase angiotensin-converting enzyme 2 (ACE2) is the only known human homologue of the key regulator of blood pressure angiotensin-converting enzyme (ACE). Since its discovery in 2000, ACE2 has been implicated in heart function, hypertension and diabetes, with its effects being mediated, in part, through its ability to convert angiotensin II to angiotensin-(1–7). Unexpectedly, ACE2 also serves as the cellular entry point for the severe acute respiratory syndrome (SARS) virus and the enzyme is therefore a prime target for pharmacological intervention on several disease fronts.</description><subject>Animals</subject><subject>Blood Vessels - metabolism</subject><subject>Blood Vessels - physiology</subject><subject>Humans</subject><subject>Isoenzymes - genetics</subject><subject>Isoenzymes - physiology</subject><subject>Peptide Hormones - metabolism</subject><subject>Peptide Hormones - physiology</subject><subject>Peptide Hydrolases - physiology</subject><subject>Peptidyl-Dipeptidase A - genetics</subject><subject>Peptidyl-Dipeptidase A - physiology</subject><subject>Receptors, Virus - genetics</subject><subject>SARS Virus - genetics</subject><issn>0165-6147</issn><issn>1873-3735</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kMtKAzEUhoMotl5ewIXMyt20OcnMpCMilFIvUBCsrkMmOaMpbTMm04Jvb4YWLxvhQBb_d_4cPkIugA6AQjFcDFrbhAGjNBt0Q-GA9GEkeMoFzw9JP0J5WkAmeuQkhAWllHMGx6QHeUxEBn0yHE-m7DqpvVslWxVcg01rjQqYtC6Zj5_nydb6TUg86pg4f0aOarUMeL5_T8nr3fRl8pDOnu4fJ-NZqvMsb1NTClFxNNTkrGBcFCLjStSszKpaFUabkiNozHWleT0Czs0or7JMVCBKzUaKn5LbXW-zqVZoNK5br5ay8Xal_Kd0ysq_ydq-yze3lQKgpJzFgqt9gXcfGwytXNmgcblUa3SbELmyKAoQEWQ7UHsXgsf6-xOgsvMsF7LzLDvPshsKceny93k_K3uxEbjZARglbS16GbTFtUZjo8pWGmf_6_8C4qCOrg</recordid><startdate>20040601</startdate><enddate>20040601</enddate><creator>Turner, Anthony J</creator><creator>Hiscox, Julian A</creator><creator>Hooper, Nigel M</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20040601</creationdate><title>ACE2: from vasopeptidase to SARS virus receptor</title><author>Turner, Anthony J ; Hiscox, Julian A ; Hooper, Nigel M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c545t-d977b3ed0d5262376743a7f294bfa6dcd93e1ce5cbc3f8133d85b447b179c28a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Animals</topic><topic>Blood Vessels - metabolism</topic><topic>Blood Vessels - physiology</topic><topic>Humans</topic><topic>Isoenzymes - genetics</topic><topic>Isoenzymes - physiology</topic><topic>Peptide Hormones - metabolism</topic><topic>Peptide Hormones - physiology</topic><topic>Peptide Hydrolases - physiology</topic><topic>Peptidyl-Dipeptidase A - genetics</topic><topic>Peptidyl-Dipeptidase A - physiology</topic><topic>Receptors, Virus - genetics</topic><topic>SARS Virus - genetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Turner, Anthony J</creatorcontrib><creatorcontrib>Hiscox, Julian A</creatorcontrib><creatorcontrib>Hooper, Nigel M</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Trends in pharmacological sciences (Regular ed.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Turner, Anthony J</au><au>Hiscox, Julian A</au><au>Hooper, Nigel M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>ACE2: from vasopeptidase to SARS virus receptor</atitle><jtitle>Trends in pharmacological sciences (Regular ed.)</jtitle><addtitle>Trends Pharmacol Sci</addtitle><date>2004-06-01</date><risdate>2004</risdate><volume>25</volume><issue>6</issue><spage>291</spage><epage>294</epage><pages>291-294</pages><issn>0165-6147</issn><eissn>1873-3735</eissn><abstract>The zinc metallopeptidase angiotensin-converting enzyme 2 (ACE2) is the only known human homologue of the key regulator of blood pressure angiotensin-converting enzyme (ACE). Since its discovery in 2000, ACE2 has been implicated in heart function, hypertension and diabetes, with its effects being mediated, in part, through its ability to convert angiotensin II to angiotensin-(1–7). Unexpectedly, ACE2 also serves as the cellular entry point for the severe acute respiratory syndrome (SARS) virus and the enzyme is therefore a prime target for pharmacological intervention on several disease fronts.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>15165741</pmid><doi>10.1016/j.tips.2004.04.001</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0165-6147
ispartof Trends in pharmacological sciences (Regular ed.), 2004-06, Vol.25 (6), p.291-294
issn 0165-6147
1873-3735
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7119032
source MEDLINE; Elsevier ScienceDirect Journals
subjects Animals
Blood Vessels - metabolism
Blood Vessels - physiology
Humans
Isoenzymes - genetics
Isoenzymes - physiology
Peptide Hormones - metabolism
Peptide Hormones - physiology
Peptide Hydrolases - physiology
Peptidyl-Dipeptidase A - genetics
Peptidyl-Dipeptidase A - physiology
Receptors, Virus - genetics
SARS Virus - genetics
title ACE2: from vasopeptidase to SARS virus receptor
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T05%3A55%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=ACE2:%20from%20vasopeptidase%20to%20SARS%20virus%20receptor&rft.jtitle=Trends%20in%20pharmacological%20sciences%20(Regular%20ed.)&rft.au=Turner,%20Anthony%20J&rft.date=2004-06-01&rft.volume=25&rft.issue=6&rft.spage=291&rft.epage=294&rft.pages=291-294&rft.issn=0165-6147&rft.eissn=1873-3735&rft_id=info:doi/10.1016/j.tips.2004.04.001&rft_dat=%3Cproquest_pubme%3E71966617%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=71966617&rft_id=info:pmid/15165741&rft_els_id=S0165614704000975&rfr_iscdi=true